... practical significance for human disease conditions. The second category of cardiac diseases comprises disorders, such as left ventricular dysfunction from valvular heart diseases or hypertension ... failure and in human disease strongly argues for the existence of a 1 -AR as a purposeful and productive resource for adaptive regulation of contrac- tility in response to cardiac disease. Although ... conditions in the most appropriate fashion in disease. Implications of receptor crosstalk for pharmacological treatment of cardiac disease Traditionally, the search for the most appropriate thera- peutic...
Ngày tải lên: 21/02/2014, 15:20
... or end-stage renal failure [8]. The prevalence of Fabry disease is estimated at 1 : 40 000 for the classic form. The incidence of the variant form of Fabry disease was found to be higher. Screening of various ... weightặday )1 for 2 weeks [47]. No apparent toxic effects were observed in transgenic mice treated with DGJ for 140 days, indicating that DGJ is well toler- ated in mice. ASSC therapy for Fabry disease ... quality of life. Perspective of DGJ treatment for Fabry disease To date, ERT is the only available Food and Drug Administration approved therapy for Fabry disease. ERT has clear advantages in that...
Ngày tải lên: 30/03/2014, 03:20
gene therapy for liver disease
... Ideally, however, gene therapy can be accomplished to correct genetic defects by in vivo methods. Ideally, a vehicle for in vivo gene therapy for the treatment of liver disease must be liver specific, ... acquired diseases such as viral infections of the liver. ã There are two basic approaches for gene transfer into hepatocytes: ex vivo and in vivo strategies. ã A vehicle for in vivo gene therapy for ... days posttreatment. The decline lasted for approximately 2 weeks, after which there was a gradual rise in DNA levels. 172 GENE THERAPY FOR LIVER DISEASE therapy is that only dividing cells are...
Ngày tải lên: 10/04/2014, 22:11
Optimal Medical Therapy with or without PCI for Stable Coronary Disease potx
Ngày tải lên: 27/06/2014, 00:20
Báo cáo y học: " Chitosan Interferon-c Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses" pps
Ngày tải lên: 08/08/2014, 21:20
Báo cáo y học: "Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder&
... been published regarding the improvement of HRQL for chil- dren with ADHD receiving pharmacotherapy, primarily atomoxetine, a nonstimulant medication approved by the FDA for the treatment of ADHD [38-46]. ... helped by behavioral interventions and therapy/ counseling WITHOUT medication ã ADHD can be helped by behavioral interventions and therapy/ counseling with medication ã ADHD can't really be ... of 12 (page number not for citation purposes) ã How embarrassed do you think your child is about taking ADHD medication at school? ã How much does your child resist taking medication at school? ã...
Ngày tải lên: 25/10/2012, 10:06
Báo cáo y học: "Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya"
... use standard encounter forms at all AMPATH clinic visits http://amrs.iukenya.org/download/forms , recording information from patient interviews and exams on paper forms. Data from the paper forms are subsequently entered ... analyses were performed using Stata/SE 9.2 for Windows (Stata Corp, College Sta- tion, TX). For the qualitative analysis, the audio-recordings and field notes from the key informant interviews ... Medicine and Associate Program Manager for the AMPATH partnership, serving as the Co-Director for the AMPATH research network. He is also the Pediatrician-In- Charge for the AMPATH Pediatric HIV Care...
Ngày tải lên: 25/10/2012, 10:31
Báo cáo y học: "Oral Rehydration Therapy for Preoperative Fluid and Electrolyte Management"
... 4. Eligibility standard for oral rehydration therapy I. Patients eligible for oral rehydration therapy (receiving oral rehydration solution) 1. Those who give an informed consent and have not ... an oxygen therapy at home for chronic obstructive respiratory disease, was in grade III of the ASA physical status classification and, basically, was not the patient ap- propriate for the ORT ... and electrolyte management is usually performed by intravenous therapy. We investigated the safety and effectiveness of oral rehydration therapy (ORT) for preoperative fluid and electrolyte...
Ngày tải lên: 25/10/2012, 10:51
Báo cáo y học: "Percutaneous laser disc decompression for thoracic disc disease: report of 10 cases"
... PLDD for the treatment of thoracic disc disease, we performed a study of ten patients with thoracic discogenic pain who were unresponsive to conservative intervention. Methods We performed ... with a lumbar location for the major- ity of intervertebral disc herniations, most published studies have focused on the use of PLDD for the treatment of lumbar disc disease. Thoracic discogenic ... weight across the disc, with sub- sequent relief of discogenic pain. PLDD is performed most commonly for lumbar disc disease, and pub- lished reports on the efficacy of PLDD in thoracic discogenic...
Ngày tải lên: 26/10/2012, 09:07
Bạn có muốn tìm thêm với từ khóa: